Zhao Y, Chen B, Shen L, Yu Y, et al. Tildrakizumab for Psoriasis in Patients With Current or Prior Malignancy: Methodological Considerations and Clinical Implications. Int J Dermatol 2026 Jan 16. doi: 10.1111/ijd.70269.
PMID: 41546145